ARROWHEAD PHARMACEUTICALS, INC.

Nasdaq:ARWR

Pharmaceutical Preparations·PASADENA, CA

Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California.

CEO

Anzalone Christopher Richard

CFO

Apel Daniel Joseph

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q4 2025	12/31/25	2/5/26	→
10-K	FY 2025	9/30/25	11/25/25	→
10-K/A	FY 2024	9/30/24	10/10/25	→
10-Q	Q2 2025	6/30/25	8/7/25	→
10-Q	Q1 2025	3/31/25	5/12/25	→
10-Q	Q4 2024	12/31/24	2/10/25	→
↓

Earnings Releases (8-K)

31 shown

Filed	Period
2/5/26	Q2 FY2026	→
11/25/25	Q1 FY2026	→
8/7/25	Q4 FY2025	→
5/12/25	Q3 FY2025	→
2/10/25	Q2 FY2025	→
11/26/24	Q1 FY2025	→
↓

News (8-K)

49 shown

Filed	Type	Description
1/12/26	Agreement	Entry into a Material Definitive Agreement	→
1/9/26	Agreement	Entry into a Material Definitive Agreement	→
1/6/26	Reg FD	Regulation FD Disclosure	→
11/18/25	Other	Other Events	→
9/12/25	Other	Other Events	→
9/11/25	Other	Other Events	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
1/27/26	ARS	ARS	→
1/9/26	424B5	424B5	→
1/9/26	424B5	424B5	→
1/8/26	FWP	FWP	→
1/8/26	FWP	FWP	→
1/7/26	424B5	424B5	→
↓

Filing History(1000 filings)

TypeDateAccessionPeriodSize

144

Mar 5, 2026

0001628280-26-015264

—

5.1 KB

10-Q

Feb 5, 2026

0000879407-26-00003410-Q

Dec 31, 2025

10.4 MB

8-K

Feb 5, 2026

0000879407-26-0000338-K

Feb 5, 2026

303.4 KB

ARS

Jan 27, 2026

0000879407-26-000029ARS

Jan 26, 2026

34.0 MB

DEFA14A

Jan 27, 2026

0000879407-26-000020DEFA14A

—

460.4 KB

DEF 14A

Jan 27, 2026

0000879407-26-000019DEF 14A

Jan 26, 2026

4.3 MB

SCHEDULE 13G/A

Jan 21, 2026

0002012383-26-000644

—

11.0 KB

8-K

Jan 12, 2026

0001193125-26-0105828-K

Jan 12, 2026

1.5 MB

8-K

Jan 9, 2026

0001193125-26-0079718-K

Jan 7, 2026

978.6 KB

424B5

Jan 9, 2026

0001193125-26-007968424B5

—

684.4 KB

424B5

Jan 9, 2026

0001193125-26-007962424B5

—

1.5 MB

Jan 8, 2026

0001830755-26-000004FORM 4

Jan 6, 2026

5.1 KB

Jan 8, 2026

0002081169-26-000002FORM 4

Jan 6, 2026

5.1 KB

Jan 8, 2026

0001627183-26-000003FORM 4

Jan 6, 2026

12.2 KB

305B2

Jan 8, 2026

0001193125-26-007815305B2

—

191.5 KB

FWP

Jan 8, 2026

0001193125-26-006942FWP

—

64.4 KB

FWP

Jan 8, 2026

0001193125-26-006808FWP

—

39.0 KB

424B5

Jan 7, 2026

0001193125-26-005087424B5

—

513.6 KB

424B5

Jan 7, 2026

0001193125-26-005068424B5

—

1.4 MB

8-K

Jan 6, 2026

0000879407-26-0000048-K

Jan 6, 2026

8.5 MB

Jan 5, 2026

0001627183-26-000001FORM 4

Dec 31, 2025

33.8 KB

Jan 5, 2026

0001830755-26-000002FORM 4

Jan 5, 2026

17.4 KB

Jan 5, 2026

0001423029-26-000001FORM 4

Jan 2, 2026

8.0 KB

144/A

Jan 5, 2026

0001628280-26-000759

—

6.2 KB

144

Jan 5, 2026

0001628280-26-000582

—

6.1 KB

25 filings shown

ARROWHEAD PHARMACEUTICALS, INC.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(1000 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
3/5/26	144	144	→
1/21/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
1/8/26	305B2	305B2	→
1/5/26	144/A	144/A	→
1/5/26	144	144	→
1/5/26	144	144	→
↓